DEF 14A

Company

HAEMONETICS CORP

Filed

June 7, 2024

Period of Report

March 30, 2024

Accession Number

0000313143-24-000040

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →